Skip to main content

Table 2 Baseline data

From: The effectiveness of the Austrian disease management programme for type 2 diabetes: a cluster-randomised controlled trial

 

Intervention

Control

p-value

Number of patients at baseline

649

840

 

Percentage of women

49.0%

46.9%

0.431

Age (years ± SD)

65.4 ± 10.4

65.5 ± 10.4

0.952

HbA1c (% ± SD)

7.46 ± 1.53

7.34 ± 1.31

0.102

Creatinine (μmol/l ± SD)

84.86 ± 30.94

84.86 ± 34.48

0.922

Triglycerides (mmol/l ± SD)

2.14 ± 1.82

2.00 ± 1.73

0.122

Cholesterol (mmol/l ± SD)

5.15 ± 1.14

5.02 ± 1.09

0.022

HDL (mmol/l ± SD)

1.35 ± 0.39

1.32 ± 0.36

0.602

LDL (mmol/l ± SD)

2.87 ± 0.96

2.87 ± 0.91

0.782

Systolic blood pressure (mmHg ± SD)

141 ± 19

139 ± 17

0.122

Diastolic blood pressure (mmHg ± SD)

83 ± 11

82 ± 10

0.412

BMI (kg/m² ± SD)

30.4 ± 5.1

29.7 ± 4.9

0.012

  1. 1 Fisher's Exact Test
  2. 2 independent T-Test